lidocaine hydrochloride 20 MG/ML Topical Spray [Regenecare]

RxCUI
1012594
RxNorm name
lidocaine hydrochloride 20 MG/ML Topical Spray [Regenecare]
Display name
REGENECARE (Topical)
Full name
lidocaine hydrochloride 20 MG/ML Topical Spray [Regenecare]
Term type
SBD
Status
Active
Strength
2%
Dose form
Spray
Route
Topical
Updated
2026-06-17 07:03:04

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102010
Active start
102010
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
lidocaine hydrochloride20 MG / 1 MLlidocainelidocaine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Spray346165

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
lidocaine6387

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRRegenecare 2 % Topical Spray GelNAMES
RxNorm Namelidocaine hydrochloride 20 MG/ML Topical Spray [Regenecare]NAMES
RxNorm SynonymRegenecare 0.02 MG/MG Topical Spray GelNAMES
RxNorm SynonymRegenecare 2 % Topical Spray GelNAMES
RxNorm SynonymRegenecare 20 MG/ML Topical SprayNAMES
TTYSBDATTRIBUTES
SPL_SET_ID0eee554f-dfe0-433a-9665-8bdb95229888CODES
RxCUI1012594CODES
MMSL_CODEBD20788CODES
MMSL_CODEBD6238CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
66977-117-0466977-117REGENECARE HA lidocaine HClMPM Medical LLCM017

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M01766977-117REGENECARE HA lidocaine HClOTC MONOGRAPH DRUGMPM Medical LLC

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
66977010003rxnav_ndcsyes
66977010005rxnav_ndcsyes
66977010025rxnav_ndcsyes
66977011704rxnav_ndcsyes
66977010000rxnav_historical
66977010703rxnav_historical
66977010704rxnav_historical
66977010725rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
0eee554f-dfe0-433a-9665-8bdb95229888Regenecare 2 % Topical Spray GelSY4MP00117 MPM Regenecare HA Spray 4 fl.oz.20260105
0eee554f-dfe0-433a-9665-8bdb95229888REGENECARE HA 2 % Topical Spray HydrogelPSN4MP00117 MPM Regenecare HA Spray 4 fl.oz.20260105
0eee554f-dfe0-433a-9665-8bdb95229888Regenecare 20 MG/ML Topical SpraySY4MP00117 MPM Regenecare HA Spray 4 fl.oz.20260105
0eee554f-dfe0-433a-9665-8bdb95229888lidocaine hydrochloride 20 MG/ML Topical Spray [Regenecare]SBD4MP00117 MPM Regenecare HA Spray 4 fl.oz.20260105
0eee554f-dfe0-433a-9665-8bdb95229888Regenecare 0.02 MG/MG Topical Spray GelSY4MP00117 MPM Regenecare HA Spray 4 fl.oz.20260105

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
c3eec066-38e8-4617-b34d-2f72ffb7a324MPM Regenecare HA Gel (MP00107 - 3oz., MP00108 - 4mL, MP00112 - 0.5oz)MPM Medical LLC20260330
0eee554f-dfe0-433a-9665-8bdb95229888MP00117 MPM Regenecare HA Spray 4 fl.oz.MPM Medical LLC20260105
c3eec066-38e8-4617-b34d-2f72ffb7a324MPM Regenecare HA Gel (MP00107 - 3oz., MPoo108 - 4mL)MPM Medical LLC20251211

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCS01HALocal anestheticsATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine hydrochloride
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine hydrochloride
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD002056BurnsDISEASEmay_treatlidocaine hydrochloride
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine hydrochloride
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD006967HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD009203Myocardial InfarctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine hydrochloride
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD018754Ventricular DysfunctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine hydrochloride
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine hydrochloride
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine hydrochloride
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine hydrochloride
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH20 MG/ML (expressed as lidocaine hydrochloride)
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD20788
CODESMMSL_CODEBD6238
CODESRxCUI1012594
CODESSPL_SET_ID0eee554f-dfe0-433a-9665-8bdb95229888
NAMESPrescribable SynonymREGENECARE HA 2 % Topical Spray Hydrogel
NAMESRXNAV_STRRegenecare 2 % Topical Spray Gel
NAMESRxNorm Namelidocaine hydrochloride 20 MG/ML Topical Spray [Regenecare]
NAMESRxNorm SynonymRegenecare 0.02 MG/MG Topical Spray Gel
NAMESRxNorm SynonymRegenecare 2 % Topical Spray Gel
NAMESRxNorm SynonymRegenecare 20 MG/ML Topical Spray
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon